Literature DB >> 26891075

Economic evaluation on infant hepatitis B vaccination combined with immunoglobulin in China, 2013.

Yuan-Sheng Chen1, Hui Zheng1, Yan-Min Liu1, Fu-Zhen Wang1, Zhen-Hua Wu1, Ning Miao1, Xiao-Jin Sun1, Guo-Min Zhang1, Fu-Qiang Cui1, Xiao-Feng Liang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26891075      PMCID： PMC4964833          DOI： 10.1080/21645515.2016.1141845

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  31 in total

1.  The doses of 10 μg should replace the doses of 5 μg in newborn hepatitis B vaccination in China: A cost-effectiveness analysis.

Authors:  Juan Yin; Zhenhao Ji; Peifeng Liang; Qian Wu; Fuqiang Cui; Fuzhen Wang; Xiaofeng Liang; Guihua Zhuang
Journal:  Vaccine       Date:  2015-06-06       Impact factor: 3.641

2.  Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas.

Authors:  W J Edmunds; G F Medley; D J Nokes; C J O'Callaghan; H C Whittle; A J Hall
Journal:  Epidemiol Infect       Date:  1996-10       Impact factor: 2.451

3.  Assessment of total economic burden of chronic hepatitis B (CHB)-related diseases in Beijing and Guangzhou, China.

Authors:  Min Hu; Wen Chen
Journal:  Value Health       Date:  2009 Nov-Dec       Impact factor: 5.725

4.  Natural history and clinical management of chronic hepatitis B virus infection in children.

Authors:  Mei-Hwei Chang
Journal:  Hepatol Int       Date:  2008-03-06       Impact factor: 6.047

5.  Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.

Authors:  Sun-Young Kim; Kaafee Billah; Tracy A Lieu; Milton C Weinstein
Journal:  Am J Prev Med       Date:  2006-06       Impact factor: 5.043

6.  An economic analysis of adult hepatitis B vaccination in China.

Authors:  Hui Zheng; Fu-zhen Wang; Guo-min Zhang; Fu-qiang Cui; Zhen-hua Wu; Ning Miao; Xiao-jin Sun; Xiao-feng Liang; Li Li
Journal:  Vaccine       Date:  2015-09-16       Impact factor: 3.641

Review 7.  Hepatitis B mother--to--child transmission.

Authors:  Sylvie Ranger-Rogez; François Denis
Journal:  Expert Rev Anti Infect Ther       Date:  2004-02       Impact factor: 5.091

8.  The influence of age on the development of the hepatitis B carrier state.

Authors:  W J Edmunds; G F Medley; D J Nokes; A J Hall; H C Whittle
Journal:  Proc Biol Sci       Date:  1993-08-23       Impact factor: 5.349

9.  The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country.

Authors:  Mehlika Toy; Fatih Oguz Onder; Ramazan Idilman; Gokhan Kabacam; Jan Hendrik Richardus; Mithat Bozdayi; Meral Akdogan; Zarife Kuloglu; Aydan Kansu; Solko Schalm; Cihan Yurdaydin
Journal:  Eur J Health Econ       Date:  2012-07-20

10.  HBV perinatal transmission.

Authors:  Muhammad Umar; Shifa Umar; Haider Ali Khan
Journal:  Int J Hepatol       Date:  2013-04-22
View more
  3 in total

1.  Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobulin treatment: a case study in Zhejiang Province, East China.

Authors:  Yanbing Zeng; Mingliang Luo; Jianlin Lin; Hanqing He; Xuan Deng; Shuyun Xie; Ya Fang
Journal:  Hum Vaccin Immunother       Date:  2019-11-26       Impact factor: 3.452

Review 2.  Economic evaluations of HBV testing and treatment strategies and applicability to low and middle-income countries.

Authors:  Shevanthi Nayagam; Elisa Sicuri; Maud Lemoine; Philippa Easterbrook; Lesong Conteh; Timothy B Hallett; Mark Thursz
Journal:  BMC Infect Dis       Date:  2017-11-01       Impact factor: 3.090

Review 3.  A systematic review of hepatitis B screening economic evaluations in low- and middle-income countries.

Authors:  Cameron M Wright; Lydia Boudarène; Ninh Thi Ha; Olivia Wu; Neil Hawkins
Journal:  BMC Public Health       Date:  2018-03-20       Impact factor: 3.295
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.